Kangmei Pharmaceutical Co., Ltd. (600518.SS)
CNY 1.98
(-0.5%)
CNY 1.98
(-0.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 102.52 Million CNY | 103.81% |
| 2022 | -2.69 Billion CNY | -134.03% |
| 2021 | 7.91 Billion CNY | 125.46% |
| 2020 | -31.09 Billion CNY | -567.98% |
| 2019 | -4.65 Billion CNY | -1343.07% |
| 2018 | 374.49 Million CNY | -90.87% |
| 2017 | 4.1 Billion CNY | 22.77% |
| 2016 | 3.34 Billion CNY | 21.17% |
| 2015 | 2.75 Billion CNY | 20.6% |
| 2014 | 2.28 Billion CNY | 21.6% |
| 2013 | 1.87 Billion CNY | 30.43% |
| 2012 | 1.44 Billion CNY | 43.4% |
| 2011 | 1 Billion CNY | 40.46% |
| 2010 | 715.52 Million CNY | 42.67% |
| 2009 | 501.5 Million CNY | 70.25% |
| 2008 | 294.57 Million CNY | 101.61% |
| 2007 | 146.1 Million CNY | 46.27% |
| 2006 | 99.88 Million CNY | 37.5% |
| 2005 | 72.64 Million CNY | 2.02% |
| 2004 | 71.21 Million CNY | 39.07% |
| 2003 | 51.2 Million CNY | 16.82% |
| 2002 | 43.83 Million CNY | 50.33% |
| 2001 | 29.15 Million CNY | 18.75% |
| 2000 | 24.55 Million CNY | 21.69% |
| 1999 | 20.17 Million CNY | 59.21% |
| 1998 | 12.67 Million CNY | 60.02% |
| 1997 | 7.91 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -10.74 Million CNY | -229.63% |
| 2024 Q2 | 8.28 Million CNY | 10.94% |
| 2024 Q1 | 7.47 Million CNY | -97.02% |
| 2023 Q3 | -22.15 Million CNY | 70.64% |
| 2023 Q2 | -75.44 Million CNY | -51.61% |
| 2023 FY | 102.52 Million CNY | 103.81% |
| 2023 Q1 | -49.76 Million CNY | 97.25% |
| 2023 Q4 | 250.53 Million CNY | 1231.01% |
| 2022 Q1 | -111.55 Million CNY | -101.25% |
| 2022 Q4 | -1.8 Billion CNY | -162.39% |
| 2022 Q2 | -83.95 Million CNY | 24.74% |
| 2022 FY | -2.69 Billion CNY | -134.03% |
| 2022 Q3 | -689.53 Million CNY | -721.33% |
| 2021 Q1 | -595.23 Million CNY | 97.65% |
| 2021 FY | 7.91 Billion CNY | 125.46% |
| 2021 Q2 | -334.3 Million CNY | 43.84% |
| 2021 Q3 | -95.05 Million CNY | 71.57% |
| 2021 Q4 | 8.94 Billion CNY | 9507.66% |
| 2020 Q1 | -296.62 Million CNY | 93.68% |
| 2020 Q2 | -1.12 Billion CNY | -280.01% |
| 2020 Q4 | -25.36 Billion CNY | -2576.44% |
| 2020 Q3 | -947.69 Million CNY | 15.93% |
| 2020 FY | -31.09 Billion CNY | -567.98% |
| 2019 Q2 | -135.37 Million CNY | -161.29% |
| 2019 Q4 | -4.69 Billion CNY | -8870.37% |
| 2019 Q3 | -52.32 Million CNY | 61.35% |
| 2019 FY | -4.65 Billion CNY | -1343.07% |
| 2019 Q1 | 220.87 Million CNY | 106.36% |
| 2018 Q3 | 1.24 Billion CNY | 5.18% |
| 2018 FY | 374.49 Million CNY | -90.87% |
| 2018 Q1 | 1.42 Billion CNY | 49.81% |
| 2018 Q2 | 1.18 Billion CNY | -16.98% |
| 2018 Q4 | -3.47 Billion CNY | -379.45% |
| 2017 Q4 | 949.94 Million CNY | -4.95% |
| 2017 Q1 | 1.06 Billion CNY | 42.62% |
| 2017 Q2 | 1.08 Billion CNY | 1.5% |
| 2017 FY | 4.1 Billion CNY | 22.77% |
| 2017 Q3 | 999.43 Million CNY | -7.78% |
| 2016 Q1 | 989.03 Million CNY | 52.34% |
| 2016 FY | 3.34 Billion CNY | 21.17% |
| 2016 Q4 | 748.66 Million CNY | -9.33% |
| 2016 Q3 | 825.7 Million CNY | 6.27% |
| 2016 Q2 | 776.99 Million CNY | -21.44% |
| 2015 FY | 2.75 Billion CNY | 20.6% |
| 2015 Q4 | 649.24 Million CNY | -3.76% |
| 2015 Q3 | 674.59 Million CNY | 9.72% |
| 2015 Q2 | 614.82 Million CNY | -24.85% |
| 2015 Q1 | 818.07 Million CNY | 3.86% |
| 2014 Q1 | 591.05 Million CNY | 19.92% |
| 2014 FY | 2.28 Billion CNY | 21.6% |
| 2014 Q4 | 787.68 Million CNY | 67.06% |
| 2014 Q3 | 471.49 Million CNY | 8.23% |
| 2014 Q2 | 435.64 Million CNY | -26.29% |
| 2013 FY | 1.87 Billion CNY | 30.43% |
| 2013 Q3 | 442.41 Million CNY | 14.43% |
| 2013 Q1 | 557.88 Million CNY | 28.3% |
| 2013 Q2 | 386.63 Million CNY | -30.7% |
| 2013 Q4 | 492.87 Million CNY | 11.41% |
| 2012 Q2 | 303.39 Million CNY | -25.0% |
| 2012 Q1 | 404.55 Million CNY | 11.08% |
| 2012 Q3 | 298.42 Million CNY | -1.64% |
| 2012 Q4 | 434.81 Million CNY | 45.71% |
| 2012 FY | 1.44 Billion CNY | 43.4% |
| 2011 FY | 1 Billion CNY | 40.46% |
| 2011 Q4 | 364.21 Million CNY | 77.57% |
| 2011 Q3 | 205.11 Million CNY | 4.43% |
| 2011 Q2 | 196.4 Million CNY | -17.93% |
| 2011 Q1 | 239.3 Million CNY | -1.92% |
| 2010 Q1 | 169.21 Million CNY | -6.33% |
| 2010 Q3 | 162.33 Million CNY | 15.97% |
| 2010 Q4 | 243.99 Million CNY | 50.3% |
| 2010 FY | 715.52 Million CNY | 42.67% |
| 2010 Q2 | 139.98 Million CNY | -17.27% |
| 2009 Q4 | 180.64 Million CNY | 78.92% |
| 2009 Q2 | 110.82 Million CNY | 1.61% |
| 2009 FY | 501.5 Million CNY | 70.25% |
| 2009 Q3 | 100.96 Million CNY | -8.9% |
| 2009 Q1 | 109.07 Million CNY | -2.55% |
| 2008 Q2 | 66.48 Million CNY | 9.15% |
| 2008 Q1 | 60.91 Million CNY | 31.49% |
| 2008 FY | 294.57 Million CNY | 101.61% |
| 2008 Q4 | 111.92 Million CNY | 102.6% |
| 2008 Q3 | 55.24 Million CNY | -16.91% |
| 2007 Q4 | 46.32 Million CNY | 26.17% |
| 2007 FY | 146.1 Million CNY | 46.27% |
| 2007 Q1 | 22.41 Million CNY | -10.97% |
| 2007 Q3 | 36.71 Million CNY | -9.68% |
| 2007 Q2 | 40.65 Million CNY | 81.35% |
| 2006 Q3 | 27.58 Million CNY | -6.95% |
| 2006 FY | 99.88 Million CNY | 37.5% |
| 2006 Q1 | 17.48 Million CNY | -8.65% |
| 2006 Q2 | 29.64 Million CNY | 69.59% |
| 2006 Q4 | 25.17 Million CNY | -8.72% |
| 2005 Q3 | 18.48 Million CNY | -7.54% |
| 2005 Q1 | 15.02 Million CNY | -23.97% |
| 2005 Q4 | 19.13 Million CNY | 3.51% |
| 2005 FY | 72.64 Million CNY | 2.02% |
| 2005 Q2 | 19.99 Million CNY | 33.06% |
| 2004 Q4 | 19.76 Million CNY | 2.47% |
| 2004 Q3 | 19.28 Million CNY | -10.95% |
| 2004 Q2 | 21.65 Million CNY | 106.28% |
| 2004 Q1 | 10.49 Million CNY | -33.82% |
| 2004 FY | 71.21 Million CNY | 39.07% |
| 2003 Q3 | 9.79 Million CNY | -37.36% |
| 2003 Q1 | 9.9 Million CNY | 34.98% |
| 2003 FY | 51.2 Million CNY | 16.82% |
| 2003 Q2 | 15.64 Million CNY | 57.95% |
| 2003 Q4 | 15.86 Million CNY | 61.94% |
| 2002 Q3 | 10.41 Million CNY | -42.21% |
| 2002 Q2 | 18.01 Million CNY | 123.44% |
| 2002 Q1 | 8.06 Million CNY | 0.0% |
| 2002 FY | 43.83 Million CNY | 50.33% |
| 2002 Q4 | 7.33 Million CNY | -29.54% |
| 2001 FY | 29.15 Million CNY | 18.75% |
| 2000 FY | 24.55 Million CNY | 21.69% |
| 1999 FY | 20.17 Million CNY | 59.21% |
| 1998 FY | 12.67 Million CNY | 60.02% |
| 1997 FY | 7.91 Million CNY | 0.0% |